Inventor · disambiguated record
Ludwig Aigner
Also filed as: AIGNER LUDWIG
9 granted patents·4 pending applications·39 citations·filing 2005–2022
85Inventor score
Files withINTELGENX CORP5AIGNER LUDWIG3BOGDAHN ULRICH2COUILLARD-DESPRES SÉBASTIEN2HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
13 records- 0189US10722476B2Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2018·Granted Jul 28, 2020·3 cites·12 claims
- 0287US7947448B2Use of regulatory sequences for specific, transient expression in neuronal determined cellsHOFFMANN LA ROCHE·Filed 2008·Granted May 24, 2011·17 cites·20 claims
- 0386US9949934B1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2016·Granted Apr 24, 2018·5 cites·3 claims
- 0479US8283334B2Inhibitors of TGF-R signaling for treatment of CNS disordersBOGDAHN ULRICH·Filed 2011·Granted Oct 9, 2012·7 cites·4 claims
- 0577US8022045B1Inhibitors of TGF-R-signaling for treatment of CNS disordersBOGDAHN ULRICH·Filed 2005·Granted Sep 20, 2011·5 cites·4 claims
- 0667US9956199B2Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disordersAIGNER LUDWIG·Filed 2016·Granted May 1, 2018·1 cites·17 claims
- 0767US2022395452A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 0863US9527860B2Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disordersAIGNER LUDWIG·Filed 2012·Granted Dec 27, 2016·1 cites·15 claims
- 0961US2019290595A1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2019·Application pending·0 cites
- 1059US2019133925A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 1148US8815505B2Use of regulatory sequences for specific, transient expression in neuronal determined cellsCOUILLARD-DESPRES SÉBASTIEN·Filed 2010·Granted Aug 26, 2014·0 cites·24 claims
- 1245US8841430B2Use of regulatory sequences for specific, transient expression in neuronal determined cellsCOUILLARD-DESPRES SÉBASTIEN·Filed 2010·Granted Sep 23, 2014·0 cites·27 claims
- 1337US2015322049A1Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's diseaseAIGNER LUDWIG·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ludwig Aigner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →